Production of sinusoidal endothelium-stimulating factors enables B16 melanoma cells to metastasize in liver by interleukin-1-dependent mechanism

被引:0
|
作者
Mendoza, L [1 ]
Carrascal, T [1 ]
Fuentes, AM [1 ]
Anasagasti, MJ [1 ]
Martin, J [1 ]
De Luca, M [1 ]
Vidal-Vanaclocha, F [1 ]
机构
[1] Univ Basque Country, Dept Cellular Biol & Morphol Sci, Sch Med & Dent, Leioa 48940, Vizcaya, Spain
来源
CELLS OF THE HEPATIC SINUSOID, VOL 7 | 1999年
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Interleukin-1beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) have been involved in melanoma-endothelial cell adhesion and metastasis by very late antigen-4 (VLA-4)/vascular cell adhesion molecule-1 (VCAM-1)-mediated interaction. However, most metastasizing melanoma cells are unable to produce these pro-inflammatory cytokines, and, therefore, how endothelial cell expression of VCAM-1 is upregulated during capillary transit of metastasizing melanoma cells is unclear. We tested the hypothesis that melanoma cell-derived factors would stimulate endothelial cell secretion of IL-1 beta and TNF-alpha, thus upregulating its VCAM-1-dependent adhesiveness. Primary cultured mouse hepatic sinusoidal endothelium (HSE) cells were treated or not with B16 melanoma (B16M) cell-conditioned medium (CM), and their adhesiveness and secretion of IL-1 beta and TNF-alpha determined along time. Recombinant human IL-1 receptor antagonist (IL-1Ra) and mouse TNF-alpha soluble receptor (TNF- alpha sR) were used to study the possible role of HSE-derived IL-1 beta and TNF-alpha in the control of HSE adhesiveness. Anti-mouse VCAM-1 antibodies were used to determine the contribution of VCAM-1 to the mechanism of adhesion to HSE and metastasis of intrasplenically-injected B16M cells. B16M-CM significantly (p < 0.01) increased in vitro HSE cell production of TNF-alpha and IL-1 beta, and their adhesiveness for other B16M cells. There was a statistically significant (p < 0.01) increase of B16M cell adhesion to HSE isolated on the 10th hour from B16M cell intrasplenically-injected mice, compared to HSE from saline-injected mice. Anti-mouse VCAM-1 antibodies abolished B16M-dependent HSE adhesion augmentation, and 70-80% inhibited hepatic metastasis, indicating that other VCAM-1-independent cytokine-induced adhesion mechanisms very little contributed to metastasis formation in this system. Addition of either TNF-alpha sR or IL-1Ra together with B16M-CM to HSE significantly (p < 0.01) reduced HSE adhesiveness (p < 0.01) by 75% as compared to untreated HSE. Moreover, complete abrogation of B16M-CM-dependent adhesion was found when HSE cells received TNF-a sR plus IL-1Ra together with B16M-CM. Thus, production of TNF-alpha- and IL-1 beta-stimulating factors, which subsequently increased VCAM-1-dependent adhesion in HSE, may constitute a relevant phenotypic property of non-IL-1 producing melanoma cells able to metastasize in liver by IL-1-dependent mechanism.
引用
收藏
页码:278 / 282
页数:5
相关论文
共 24 条
  • [1] Interleukin-1-mediated H2O2 production by hepatic sinusoidal endothelium in response to B16 melanoma cell adhesion
    Anasagasti, MJ
    Alvarez, A
    Avivi, C
    VidalVanaclocha, F
    JOURNAL OF CELLULAR PHYSIOLOGY, 1996, 167 (02) : 314 - 323
  • [2] Interleukin-18 binding protein reduces B16 melanoma hepatic metastasis by neutralizing adhesiveness and growth factors of sinusoidal endothelium
    Carrascal, MT
    Mendoza, L
    Valcárcel, M
    Salado, C
    Egilegor, E
    Tellería, N
    Vidal-Vanaclocha, F
    Dinarello, CA
    CANCER RESEARCH, 2003, 63 (02) : 491 - 497
  • [3] Inhibition of proteasome-mediated IκB degradation blocks hepatic metastasis via downregulation of NFκB-dependent endothelium-stimulating factor production from melanoma cells.
    Mendoza, L
    Carrascal, T
    Martin, JJ
    de Luca, M
    Fuentes, AM
    Anasagasti, MJ
    Vidal-Vanaclocha, F
    CLINICAL CANCER RESEARCH, 1999, 5 : 3742S - 3742S
  • [4] Factors secreted by B16 melanoma cells induce nitric oxide production in RAW 264.7 macrophages - is nitric oxide contributing to B16 melanoma mediated immunosuppression and tumor facilitation?
    Bradu, S
    Michl, J
    Nowakowski, M
    Sieminska, J
    Brody, N
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 467 - 467
  • [5] Tumoricidal activity of endothelial cells -: Inhibition of endothelial nitric oxide production abrogates tumor cytotoxicity induced by hepatic sinusoidal endothelium in response to B16 melanoma adhesion in vitro
    Carretero, J
    Obrador, E
    Esteve, JM
    Ortega, A
    Pellicer, JA
    Sempere, FV
    Estrela, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (28) : 25775 - 25782
  • [6] Torilin from Torilis japonica Inhibits Melanin Production in α-Melanocyte Stimulating Hormone-Activated B16 Melanoma Cells
    Yun, Cheong-Yong
    Kim, Dongchun
    Lee, Won-Hee
    Park, Yu Mi
    Lee, Seung Ho
    Na, Minkyun
    Jahng, Yurngdong
    Hwang, Bang Yeon
    Lee, Mi Kyeong
    Han, Sang-Bae
    Kim, Youngsoo
    PLANTA MEDICA, 2009, 75 (14) : 1505 - 1508
  • [7] Tumor cytotoxicity by endothelial cells -: Impairment of the mitochondrial system for glutathione uptake in mouse B16 melanoma cells that survive after in vitro interaction with the hepatic sinusoidal endothelium
    Ortega, AL
    Carretero, J
    Obrador, E
    Gambini, J
    Asensi, M
    Rodilla, V
    Estrela, JM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) : 13888 - 13897
  • [8] B16 melanoma cells increase B-1 cell survival, IL-10 production and radioresistance in vitro
    Lucatelli Laurindo, Maria Fernanda
    Thies, Felipe Garutti
    Perez, Elizabeth Cristina
    Novaes e Brito, Ronni Romulo
    Mariano, Mario
    Popi, Ana Flavia
    IMMUNOBIOLOGY, 2013, 218 (04) : 609 - 619
  • [9] Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1β induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor
    Olle Björkdahl
    Mikael Dohlsten
    Hans-Olov Sjögren
    Cancer Gene Therapy, 2000, 7 : 1365 - 1374
  • [10] Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1β induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor
    Björkdahl, O
    Dohlsten, M
    Sjögren, HO
    CANCER GENE THERAPY, 2000, 7 (10) : 1365 - 1374